Other

Roche buys US Foundation Medicine for $2.4 bn

Swiss pharmaceutical giant Roche said Tuesday it had reached an agreement to purchase the remaining shares of US lab Foundation Medicine, of which it already holds a majority stake, for $2.4 billion.

page 1 from 3